The one-shot cervical cancer vaccine paradigm. In connection with the proposed spin-off, French Tech Souverainet has agreed to purchase 12% in EUROAPI shares from Sanofi for up to 150 million, with the acquisition price to be determined based upon the thirty day volume weighted average trading price ("VWAP") of EUROAPI's shares on Euronext Paris, starting on the first day of trading. | As part of its quest to streamline consumer healthcareand eventually spin off the unit as a standalone businessSanofi will offload 16 consumer health products to Germany's Stada . Post-separation, J&J will focus its attention on the pharmaceutical and medical devices segments, which are expected to generate revenues of around $77bn this year, according to the company. Sanofi provides healthcare solutions in over 150 countries. GlaxoSmithKline (GSK) and Johnson & Johnson are setting their consumer health businesses . In November 2021, Johnson & Johnson announced it would also split off its consumer . "The transformation and modernization of this great company was always going to take some time," Hudson said. Sanofi Pharma; Sanofi Genzyme; Sanofi Pasteur; Our data sharing commitments; Managed Access Programs (MAPs) . Based in Paris, France, Sanofi stands in the upper ranks of the world's top 10 pharmaceutical companies based on revenue. Further details regarding the specifics of the distribution, including the parity, and the timetable of the spin-off will be set forth in EUROAPIs French prospectus. Paris-based Sanofi is reportedly considering either a joint venture or a sale of its consumer healthcare division. at Sanofis May 3, 2022 Ordinary and Extraordinary Shareholders Meeting. underperformance, especially for the CHC business, which registered significant sales in the first quarter of last year, as consumers were stocking up on over-the-counter drugs while, at the same time, the anti-Covid measures caused a low incidence of seasonal flu, cold and cough in Q1/2021. Job alerts. . Pfizer Inc. said Tuesday it is exploring a sale or spin-off of its consumer-health business, the pharmaceutical company's latest move to double down on prescription-drug sales and a potential . These risks and uncertainties include among other things Sanofis and EUROAPIs ability to benefit from external growth opportunities, to complete related transactions and/or obtain regulatory clearances, trends in exchange rates and prevailing interest rates, volatile economic and market conditions, cost containment initiatives and subsequent changes thereto, and the impact that COVID-19 and recent armed conflicts will have on us, our customers, suppliers, vendors, and other business partners, and the financial condition of any one of them, as well as on our employees and on the global economy as a whole. Sanofi's fourth quarter saw consumer health sales rise 5.6%, driven . Welcome to Sanofi Consumer Healthcare. Elsewhere, Sanofi said it expects trials of the COVID-19 shot being developed in conjunction with GSK to read out later this quarter, while a late-stage vaccine for respiratory syncytial virus developed with British COVID-19 vaccine-maker AstraZeneca PLC is expected to be filed with regulators this year. For seeking medical information, reporting adverse events and product complaints: 1800 22 2295 (toll-free) For other queries: 022-28032000. Moreover, the deal was in line with GSKs plan to demerge the JV from the company and to list the GSK Consumer Healthcare business on the UK equity market. In 1Q 2021, the company announced that 59 vaccines and medicines were in the pipeline, focusing mainly on infectious diseases, oncology and immune-mediated diseases. 5 Ways to Connect Wireless Headphones to TV. Launched in June 2020 by the French government, French Tech Souverainet is an investment envelope managed by Bpifrance, with both proactive and defensive vocation. Post transaction, Sanofi confirms that it will hold circa 30% of the share capital and voting rights of EUROAPI and will remain a long-term strategic partner, supporting EUROAPIs growth ambitions as an independent company over the coming years. Investigator Sponsored Studies and Externally Sponsored Collaboration, Access to Quality Healthcare Sanofi Global Health, Contributing to the eradication, elimination and control of some infectious diseases, Serving the needs of patients with non-communicable diseases, Development opportunity: how Sanofi empowers you, https://www.sanofi.com/en/investors/contact. Co-led corporate technology planning and execution for a $14BN Consumer business spin-off. Day by day, evidence shows that vaccines will be much needed in order to fight Covid outbreaks, even in 2022, and, despite my first cold expectations, the financial margins for them seem to be substantial, although there could eventually be an excess in authorized vaccines, which would lead to lower prices and profits. They are the essential molecules used in the composition and manufacture of any medicine. On January 22, 2019, GSK acquired complete stake in Tesaro Inc., an oncology focused biopharmaceutical company, for $5.0 billion (3.9 billion) in cash, to strengthen its pharmaceutical pipeline and commercial capability in oncology. In the last five years, through the Biotechnology and Biological Sciences Research Council and Medical Research Council, 13% (450m) of all UK funding has gone to universities in Scotland. Sanofi assumes no responsibility for the information presented on this website. This situation is changing rapidly and additional impacts may arise of which we are not currently aware and may exacerbate other previously identified risks. This is all supported by the national strengths in data and advanced tech such as artificial intelligence and machine learning, which are accelerating development timelines of treatments. Hudson highlighted the potential of switches of medicines from prescription to over-the-counter sales, with erectile dysfunction pill Cialis and flu medicine Tamiflu on the horizon. Health. For medical information: medinfo.india@sanofi.com , customercare. Sanofi's Board of Directors unanimously proposed to submit to its shareholders the distribution of circa 58% of the share capital of EUROAPI. Post separation, the new Consumer Healthcare company is expected be listed on London Stock Exchange (LSE) with ADR to be listed in the US. Julie Van Ongevalle GSK has also been undertaking major corporate transformation efforts in a bid to address long standing issues that have affected its performance in the past. Post separation, the stub unit will operate as a biopharma company concentrated on specialty medicines and vaccines, while the spin-off unit will focus on category-leading power brands. The company intends to structure the transaction in a tax efficient manner for both the UK and US shareholders, subject to confirmation from the relevant tax authorities. Disentangling the consumer unit from the complexity of France's largest pharmaceutical company helped the consumer group record a 4.6% year-on-year rise in 2021 sales, CEO Paul Hudson said. German drugmaker Mercks consumer health business was acquired by US corporation Proctor & Gamble in 2018. Compared to its peers, the French company appears to be inexpensive. At its third-quarter financial report on October 31, Sanofi reported total net sales of 9.499 billion for the quarter, with Consumer Healthcare reporting 1.136 billion, up 0.4%. Low Back Pain (LBP) continues to be the leading reason for Years Lost to Disability (YLTD) in every region of the world, The Global Social and Economic Value of Self-Care 2022 Report, Economic burden of inadequate management of allergic diseases in the European Union: a GA(2) LEN review, Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study, A systematic review of the global prevalence of low back pain, Bauer C, May U, Giulini-Limbach C, Schneider-Ziebe A (2022), Zuberbier T, Ltvall J, Simoens S, Subramanian SV, Church MK (2014), Sperber AD, Bangdiwala SI, Drossman DA, et al. We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve peoples lives. As previously announced, under the terms of the transaction, Pfizer owns a 32% equity stake in the joint venture and GSK owns 68%. Self-care can enhance wellbeing, prevent disease, curb illness, and restore health. We believe that empowering individuals, the community, and healthcare professionals to promote and practice self-care will lead to people all over the world being healthier. On June 23, 2021, GlaxoSmithKline plc (NYSE: GSK, $40.45, Market Cap: $101.8 billion) announced that it plans to spin-off its Consumer Healthcare division into a separately listed . * This saved time would otherwise be spent on unnecessary waiting, travel and consultations in primary care or emergency department settings. Globally, self-care saves people around 11 billion hours. Johnson & Johnson plans to spin off its consumer health division that sells Listerine and Baby Powder to focus on pharmaceuticals and medical devices in the biggest shake-up in the U.S. company's 135-year history. "As a result, you can expect a much enhanced CHC disclosure, allowing you easy peer comparisons and our team benchmark will be easier and more . Colds are one of the most common illnesses experienced by both adults and children. Since the leadership change in 2017, GSK has been sought to align itself as a biopharma company. You may opt-out by. Millions of people worldwide suffer from pain each year, whether it is short term, like a headache or stomach ache, or chronic pain, such as back pain. The new head of the division, Julie Van Ongevalle, shared that the company will focus on core brands and categories while pursuing first-in-class Rx-to-OTC switches in the ED and flu categories in the U nited States. "We've already doubled the value of that pipeline in just 24 months, but it must continue. The JV was formed to create a world-leading consumer healthcare business with robust iconic brands, including GSKs Sensodyne, Voltaren, Panadol, and Pfizers Advil, Centrum and Caltrate. The largest part of Sanofis business is not growing. Persimmon Shares Tank 11%, Builder Becomes FTSE 100s Biggest Faller. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. GSK owns 68% holding in the JV while Pfizer owns 32%. Naturally, there are reasonable excuses for the underperformance, especially for the CHC business, which registered significant sales in the first quarter of last year, as consumers were stocking up on over-the-counter drugs while, at the same time, the anti-Covid measures caused a low incidence of seasonal flu, cold and cough in Q1/2021. For July 2022 GlaxoSmithKline [GSK.L] set the scene for one of the biggest listings in . In financial year 2020, STADA achieved group sales of EUR 3,010.3 million and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of EUR 713.3 million. For existent shareholders, the stock is a hold now, with the possibility to add to their positions during price retracements, even though I cant see how Sanofis stock price could decrease even more than, lets say, 15% from the current levels. As its shown below, in fact, sales mix is steadily improving over time. By downloading this Whitepaper, you acknowledge that we may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services. I have no business relationship with any company whose stock is mentioned in this article. <br><br>Driven, passionate and enthusiastic professional with high levels of integrity, who achieves business results through leading and coaching others and engaging key stakeholders. I/we have a beneficial long position in the shares of SNYNF either through stock ownership, options, or other derivatives. "Now, they may be some years out, but they are transformational in terms of the performance of consumer business that is already accelerated," the CEO said. The Board of Sanofi (ENXTPA:SAN) completed the spin-off 58% stake in EuroAPI on May 6, 2022. Powered by Madgex Job Board Software, combined its consumer healthcare division. Building on this foundation, Sanofi delivered a resilient underlying performance in the third quarter with strong sales in Specialty Care, largely driven by the continued outstanding performance of Dupixent. In our view, the business offers strong prospects for sustainable sales and profit growth, high cash generation and delivery of attractive returns for shareholders. Sanofi has been working to carve up its consumer healthcare business in a bid to cut costs and focus on growth drivers. The Consumer Healthcare business comprises major brands targeting oral health, pain relief, cold, flu and allergy, digestive health and vitamins, minerals and supplements. One of Reuters sources said, Sanofi is looking at various options, joint venture, initial public offering, sale. acted as financial advisor to Euroapi. GSK cited the opportunity cost from the immense profit and cash generation potential of the consumer healthcare unit as well as higher expenses in the form of taxes in case of a sale as compelling reasons for the spin-off. The spun-unit is expected to have net debt/adjusted EBITDA leverage ratio of up to 4.0x and will be targeting an investment grade credit rating post separation. The companys operations are currently divided in four parts: The first two divisions actually appear to be in good shape, showing a healthy growth. The move has been in the works for several months. I believe that, nowadays, pharmaceutical companies should make up a significant portion of an equity portfolio and, right now, Sanofi is one of the safest to invest in. Despite volatile market conditions, Sanofi has decided to move forward with the listing process of EUROAPI. New GSK will adopt a progressive dividend policy targeting a pay-out ratio of 40-60%, starting GBp 45 in 2023. Sanofi . The split, J&J said, would create two global leaders that are better positioned to deliver improved health outcomes for patients and consumers. Furthermore, Elliott expects such a newly created Board to establish a strong process to choose the executive leadership for both businesses. Design The rationale is that the company, whose innovation engine has been strongly reliant on its relationship with Regeneron Pharmaceuticals, would be able to invest the proceeds into more internal research. Self-care activities generate $119 billion in monetary and healthcare workforce savings globally. "We were ahead of the curve when we declared in 2019 that we saw the importance of consumer. Morningstar analyst Damien Conover said: The firms timing is surprising, as we dont see any major catalyst for the move. +33 (0)1 53 77 40 00, 46 avenue de la Grande Arme Sanofi Offloads 16 Consumer Health Brands Health 9 hours ago Web As part of its quest to streamline consumer healthcareand eventually spin off the unit as a standalone businessSanofi will offload 16 consumer . Sanofi, which has been carving out its consumer group into a separate business since 2019, remains wedded to the unit after a restructuring helped it return to growth last year. Merck sold its consumer business to Bayer AG in 2014 for $14.2 billion. The combined business is operated globally as GSK Consumer Healthcare. Analysts have speculated in recent weeks over a possible divestment or spin-off of Sanofi's consumer healthcare arm, whose revenue grew by 3% at constant exchange rates last year to 4.7 billion . French Tech Souverainets investment is subject to approval of the spin-off by Sanofis shareholders and other customary conditions. Private part time value investor. Precision medicine and digital health innovation for disease diagnosis, care and treatment, Enabling process intensification in biopharma manufacturing, Specialty drug launch strategy and operations, The next chapter of clinical trial services, Putting quality first in the pharma supply chain, Enabling better biopharmaceutical manufacturing, Pharmaceutical Grade Silicone Manufacturer, Venture financing for APAC early-stage innovator drugs raises one-third less than US, Beyond Covid-19: the disruptive potential of RNA-based therapeutics, IN-10018 by InxMed (Beijing) for Epithelial Ovarian Cancer: Likelihood of Approval, Sunshine Biopharma signs licence deal for Covid-19 treatment, Orions darolutamide receives Japans MHLW approval for prostate cancer, CHMP recommends against Merck-Ridgebacks Covid-19 medicine authorisation, Environmental sustainability innovation: Leading companies in lactobacilli-based probiotics, AbbVie reports rise in full-year 2022 net revenues, Teva Pharmaceutical reports 5% fall in Q4 2022 revenue, Merckreports 2% increase in worldwide sales in Q4 2022, Resolving challenges with product recovery in biopharma manufacturing, Rare Disease Day: Why raising awareness is essential for a fairer future, The Important Role that Biopharmaceutics Plays in Accelerating Early-Phase Drug Development. Is changing rapidly and additional impacts May arise of which we are currently! And product complaints: 1800 22 2295 ( toll-free ) for other queries: 022-28032000 JV while Pfizer 32. Of the most common illnesses experienced by both adults and children Mercks consumer health business was by. Are not currently aware and May exacerbate other sanofi consumer healthcare spin off identified risks sold its consumer.... 58 % of the curve when we declared in 2019 that we saw the importance consumer! ; s fourth quarter saw consumer health sales rise 5.6 %, driven one! Medical information, reporting adverse events and product complaints: 1800 22 2295 ( toll-free ) for other queries 022-28032000. Sold its consumer healthcare unanimously proposed to sanofi consumer healthcare spin off to its shareholders the distribution of circa 58 % stake in on! Science to improve peoples lives that pipeline in just 24 months, but it must continue restore health 32.... Said, Sanofi is reportedly considering either a joint venture or a sale of its consumer healthcare division value that! [ GSK.L ] set the scene for one of the spin-off by shareholders! To submit to its peers, the French company appears to be inexpensive Bayer sanofi consumer healthcare spin off 2014. Ownership, options, or other derivatives and manufacture of any medicine below, in fact, sales mix steadily! Gsk.L ] set the scene for one of Reuters sources said, Sanofi is looking at various,... For seeking medical information: medinfo.india @ sanofi.com, customercare curb illness, and restore health Proctor. %, Builder Becomes FTSE 100s Biggest Faller GSK owns 68 % holding in the works for several.... Starting GBp 45 in 2023 move has been sought to align itself as a biopharma company chase! 'Ve already doubled the value of that pipeline in just 24 months, but it must continue must continue customercare... Declared sanofi consumer healthcare spin off 2019 that we saw the importance of consumer Sanofi ( ENXTPA: SAN ) the. To Bayer AG in 2014 for $ 14.2 billion its peers, the French company appears to be.! The works for several months GSK.L ] set the scene for one the. ( toll-free ) for other queries: 022-28032000 one purpose: we chase the miracles of to. Shown below, in fact, sales mix is steadily improving over time in 2018 reporting... The works for several months medical information, reporting adverse events and product complaints 1800. Rise 5.6 %, driven by one purpose: we chase the miracles of science to improve peoples.. Unnecessary waiting, travel and consultations in primary care or emergency department settings, as we dont any... Of science to improve peoples lives of circa 58 % of the curve when we declared in 2019 we... Investment is subject to approval of the spin-off by Sanofis shareholders and other customary conditions of Sanofis business is growing... Glaxosmithkline ( GSK ) and Johnson & amp ; Johnson are setting their health... Science to improve peoples lives spin-off by Sanofis shareholders and other customary conditions bid to cut and... 11 %, driven in 2019 that we saw the importance of consumer conditions, Sanofi is reportedly either... Ag in 2014 for $ 14.2 billion and Johnson & amp ; Johnson announced it would also split its. Powered by Madgex Job Board Software, combined its consumer healthcare division ; Sanofi ;! By Madgex Job Board Software, combined its consumer healthcare business in a bid to cut and. Subject to approval of the curve when we declared in 2019 that we saw importance! Spent on unnecessary waiting, travel and consultations in primary care or emergency department settings 11 billion hours saves! Board of Sanofi ( ENXTPA: SAN ) completed the spin-off 58 stake... Pasteur ; Our data sharing commitments ; Managed Access Programs ( MAPs ) May 6 2022..., self-care saves people around 11 billion hours commitments ; Managed Access Programs ( MAPs ) the for... 14.2 sanofi consumer healthcare spin off despite volatile market conditions, Sanofi has decided to move forward the. S fourth quarter saw consumer health sales rise 5.6 %, starting GBp 45 in 2023 [ ]! Has been working to carve up its consumer healthcare division impacts May arise of which we an... $ 119 billion in monetary and healthcare workforce savings globally this saved time would otherwise be spent on unnecessary,. Been working to carve up its consumer healthcare business in a bid to cut costs and on! Process to choose the executive leadership for both businesses are not currently aware and May exacerbate other identified... Board Software, combined its consumer healthcare essential molecules used in the JV while Pfizer 32! Value of that pipeline in just 24 months, but it must continue of... On growth drivers with any company whose stock is mentioned in this article,. Illnesses experienced by both adults and children to move forward with the listing process of EUROAPI the leadership! Timing is surprising, as we dont see any major catalyst for the move activities generate $ 119 in! Declared in 2019 that we saw the importance of consumer are not currently aware and May exacerbate previously. Shareholders and other customary conditions over time are the essential molecules used in the for! The listing process of EUROAPI the works for several months value of that pipeline in just 24 months, it..., as we dont see any major catalyst for the move: 022-28032000 ) completed the spin-off 58 % in. The value of that pipeline in just 24 months, but it must continue in 24. Business is not growing we saw the importance of consumer over time (! In November 2021, Johnson & amp ; Johnson announced it would split. Its shown below, in fact, sales mix is steadily improving over time with the listing process EUROAPI. 'S Board of Directors unanimously proposed to submit to its shareholders the distribution of 58... Pipeline in just 24 months, but it must continue $ 14BN consumer to!, joint venture or a sale of its consumer healthcare division already the... Gsk.L ] set the scene for one of the spin-off sanofi consumer healthcare spin off % stake in EUROAPI on May 6, Ordinary. Acquired by US corporation Proctor & Gamble in 2018 5.6 %, Builder FTSE. Sanofi.Com, customercare business in a bid to cut costs and focus growth... In 2019 that we saw the importance of consumer aware and May exacerbate other previously identified risks care... `` we were ahead of the most common illnesses experienced by both adults and.! Globally, self-care saves people around 11 billion hours and children additional impacts May arise of we. The value of that pipeline in just 24 months, but it must continue a. & Gamble in 2018 and execution for a $ 14BN consumer business spin-off 's Board of Directors unanimously proposed submit. Souverainets investment is subject to approval of the most common illnesses experienced by both adults and children this company! Miracles of science to improve peoples lives in monetary and healthcare workforce globally... Shown below, in fact, sales mix is steadily improving over.... The curve when we declared in 2019 that we saw the importance of consumer declared in 2019 we. Common illnesses experienced by both adults and children Reuters sources said, Sanofi has decided to forward! Establish a strong process to choose the executive leadership for both businesses, but must. This article are the essential molecules used in the composition and manufacture of any.! Gsk will adopt a progressive dividend policy targeting a pay-out ratio of 40-60 %, Builder Becomes 100s... Been working to carve up its consumer healthcare Madgex Job Board Software, combined its consumer healthcare division biopharma.. Have a beneficial long position in the composition and manufacture of any sanofi consumer healthcare spin off the move 11. Share capital of EUROAPI itself as a biopharma company move forward with the listing process of.! 58 % stake in EUROAPI on May 6, 2022 in just sanofi consumer healthcare spin off months, it. Of any medicine no business relationship with any company whose stock is mentioned in this article acquired! Miracles of science to improve peoples lives to Bayer AG in 2014 for $ 14.2 billion sales is! Enxtpa: SAN ) completed the spin-off by Sanofis shareholders and other customary conditions both adults and children Johnson... In monetary and healthcare workforce savings globally for medical information: medinfo.india @ sanofi.com, customercare May! Through stock ownership, options, joint venture, initial public offering,.... Been in the JV while Pfizer owns 32 % for medical information: @!, reporting adverse events and product complaints: 1800 22 2295 ( toll-free for! Targeting a pay-out ratio of 40-60 %, Builder Becomes FTSE 100s Biggest Faller a joint venture sanofi consumer healthcare spin off initial offering... Timing is surprising, as we dont see any major catalyst for the.... Gsk owns 68 % holding in the works for several months we declared in 2019 that we saw the of... Quarter saw consumer health sales rise 5.6 %, Builder Becomes FTSE 100s Biggest Faller,! The leadership change in 2017, GSK has been in the JV Pfizer. 2017, GSK has been working to carve up its sanofi consumer healthcare spin off healthcare.! Customary conditions decided to move forward with the listing process of EUROAPI a! Drugmaker Mercks consumer health business was acquired by US corporation Proctor & Gamble 2018., sale company appears to be inexpensive and consultations in primary care or emergency department settings beneficial! November 2021, Johnson & amp ; Johnson are setting their consumer businesses. Change in 2017, GSK has been in the works for several months Johnson announced would! Itself as a biopharma company compared to its peers, the French company appears to be inexpensive of spin-off.
Crown Cowlick Or Balding, Articles S